Sleep in obsessive compulsive disorder: Polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency

European Archives of Psychiatry and Clinical Neuroscience

Volumn 257, Issue 3, 2007, Pages 173-182

  Voderholzer, Ulrich ^a   Riemann, Dieter ^a   Huwig Poppe, Christine ^b   Kuelz, Anne Katrin ^a   Kordon, Andreas ^c   Bruestle, Katharina ^a   Berger, Mathias ^a   Hohagen, Fritz ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Psychiatric Hospital Sanatorium Kilchberg   (Switzerland)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Obsessive compulsive disorder; Polysomnography; Serotonin; Sleep; Treatment; Tryptophan depletion test

Indexed keywords

TRYPTOPHAN;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP PATTERN; SLOW WAVE SLEEP;

ADULT; AGING; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; POLYSOMNOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; SLEEP; SLEEP STAGES; SLEEP, REM; TRYPTOPHAN;

EID: 34247104712     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-006-0708-9     Document Type: Article

References (55)

1. Angst J, Gamma A, Endrass J, Goodwin R, Ajdacic V, Eich D, Rossler W (2004) Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci 254:156-164
2. Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Blair Simpson H, Tu X (2005) Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 162:151-161
3. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ (1998) Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. Psychopharmacology 136:205-216
4. Kordon A, Kahl KG, Broocks A, Voderholzer U, Rasche-Rauchle H, Hohagen F (2005) Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two-year follow-up. Eur Arch Psychiatry Clin Neurosci 255:48-50
5. Rufer M, Hand I, Alsleben H, Braatz A, Ortmann J, Katenkamp B, Fricke S, Peter H (2005) Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: A 7-year follow-up of a randomized double-blind trial. European Archives of Psychiatry and Clinical Neuroscience 255:121-128
6. Saxena S, Rauch SL (2000) Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Pediatric Clinics of North America 23:563-586
7. Kuelz A, Hohagen F, Voderholzer U (2004) Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biological Psychology 65:185-236
8. Moritz S, Jacobsen D, Willenborg B, Jelinek L, Fricke S (2006) A check on the memory deficit hypothesis of obsessive-compulsive checking. European Archives of Psychiatry and Clinical Neuroscience 256:82-86
9. Murphy DL, Greenberg B, Altemus M, Benjamin J, Grady T, Pigott T (1996) The Neuropharmacology and Neurobiology of Obsessive-compulsive Disorder. In: Westenberg HGM (ed). Advances in the Neurobiology of Anxiety Disorders. John Wiley & Sons Ltd., Chichester, pp 279-297
10. Pigott TA, Seay SM (1999) A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 60:101-106
11. Broocks A, Pigott TA, Hill JL, Canter S, Grady TA, L'Heureux F, Murphy DL (1998) Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results. Psychiatry Res 79:11-20
12. Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR (1988) Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. Am J Psychiatry 145:1015-1017
13. Zohar J, Mueller EA, Insel TR, Zohar Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch Gen Psychiatry 44:946-951
14. Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR (1989) Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. Arch Gen Psychiatry 46:23-28
15. Kang DH, Kwon JS, Kim JJ, Youn T, Park HJ, Kim MS, Lee DS, Lee MC (2003) Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 107:291-297
16. Stengler-Wenzke K, Muller U, Angermeyer MC, Sabri O, Hesse S (2004) Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD). Eur Arch Psychiatry Clin Neurosci 254:252-255
17. Swedo SE, Leonard JL, Kruesi MJ, Rettew DC, Listwak SJ, Berrettini W, Stipetic M, Hamburger S, Gold PW, Potter WZ (1992) Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry 49:29-36
18. Baumgarten HG, Grozdanovic Z (1998) Role of serotonin in obsessive-compulsive disorder. Brit J Psychiatry 173 (Suppl. 35):13-20
19. Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH (1994) Tryptophan depletion in patients with obsessive compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry 51:309-317
20. Smeraldi E, Diaferia G, Erzegovesi S, Lucca A, Bellodi L, Moja EA (1996) Tryptophan depletion in obsessive-compulsive patients. Biol Psychiatry 40:398-402
21. Booij L, Van der Does W, Benkelfat C, Bremner JD, Cowen PJ, Fava M, Gillin C, Leyton M, Moore P, Smith KA, Van der Kloot WA (2002) Predictors of mood response to acute tryptophan depletion: a reanalysis. Neuropsychopharmacology 27:852-861
22. Hobson JA, McCarley RW, Wyzinski PW (1975) Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189:55-58
23. Bhatti T, Gillin JC, Seifritz E, Moore P, Clark C, Golshan S, Stahl S, Rapaport M, Kelsoe J (1998) Effects of a tryptophan-free amino acid drink challenge on normal human sleep EEG and mood. Biol Psychiatry 43:52-59
24. Moore P, Gillin JC, Bhatti T, DeModena A, Seifritz E, Clark C, Stahl S, Rapaport M, Kelsoe J (1998) Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Arch Gen Psychiatry 55:534-539
25. Voderholzer U, Hornyak M, Thiel B, Huwig-Poppe C, Kiemen A, König A, Backhaus J, Riemann D, Berger M, Hohagen F (1998) Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 18:112-124
26. Riemann D, Feige B, Hornyak M, Koch S, Hohagen F, Voderholzer U (2002) The tryptophan-depletion test: impact on sleep in primary insomnia - a pilot study. Psychiatry Res 109:129-135
27. Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric disorders: A meta-analysis. Arch Gen Psychiatry 49:651-668
28. Riemann D, Berger M, Voderholzer U (2001) Sleep and depression - results from psychobiological studies: an overview. Biol Psychiatry 57:67-103
29. Insel TR, Gillin JC, Moore A, Mendelson WB, Loewenstein R, Murphy DL (1982) Sleep in obsessive-compulsive disorder. Arch Gen Psychiatry 93:1372-1377
30. Walsleben J, Robinson D, Lemus C, Hackshaw R, Norman R, Alvir J (1990) Polysomnographic aspects of obsessive-compulsive disorders. Sleep Res 19:177
31. Hohagen F, Lis S, Krieger S, Winkelmann G, Riemann D, Fritsch Montero R, Rey E, Aldenhoff J, Berger M (1994) Sleep EEG of patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 243:273-278
32. Robinson D, Walsleben J, Pollack S, Lerner G (1998) Nocturnal polysomnography in obsessive-compulsive disorder. Psychiatry Res 80:257-263
33. Spitzer RL, Williams JB, Gibbons M (1984) The structured clinical interview for DSM-III-R. Biometrics Research Department, New York State Psychiatric Institute, New York
34. Wittchen HU, Zaudig M, Schramm E, Spengler P, Mombour B, Kleig J, Horn R (1988) Strukturiertes klinisches Interview für DSM-III-R (SKID-P). Beltz-Test, Weinheim
35. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989a) The Yale-Brown Obsessive Compulsive Scale: I. Development, use and reliability. Arch Gen Psychiatry 46:1012-1016
36. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989b) The Yale-Brown Obsessive Compulsive Scale: II. Validity. Arch Gen Psychiatry 46:1006-1011
37. Büttner-Westphal H, Hand I (1991) Yale-Brown Obsessive Compulsive Scale, Deutsche Übersetzung und Bearbeitung. Verhaltenstherapie 1:226-233
38. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Government Printing Office, Public Health Service, Washington, DC
39. Delgado P, Charney D, Price L, Aghajanian G, Landis H, Heninger G (1990) Serotonin and the Mechanism of Antidepressant Action. Arch Gen Psychiatry 47:411-418
40. Young SN, Smith SE, Pihl RO, Ervin FR (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87:173-177
41. Delgado P, Price S, Miller H, Salomon R, Aghajanian G, Heninger F, Charney D (1994) Serotonin and the Neurobiology of Depression. Effects of Tryptophan Depletion in Drug-Free Depressed Patients. Arch Gen Psychiatry 51:865-874
42. Zerssen von D (1986) Clinical Self-Rating Scales (CSRS) of the Munich Psychiatry Information System (PSYCHIS München). In: Sartorius N, Ban TA (eds). Assessment of Depression. Springer, Berlin Heidelberg New York, Tokyo, pp 270-303
43. Bech P, Gram LF, Dein E, Jacobson O, Vitger J, Bohuys TG (1975) Quantitative ratings of depressive states. Acta Psychiatrica Scand 51:161-170
44. Saletu-Zyhlarz G, Saletu G, Anderer P, Brandstatter N, Frey R, Gruber G, Klosch G, Mandl M, Grunberger J, Linzmayer L (1997) Nonorganic insomnia in generalized anxiety disorder. Neuropsychobiol 36:117-129
45. Stein MB, Enns MW, Kryger MH (1993) Sleep in nondepressed patients with panic disorder: II. polysomnographic assessment of sleep architecture and sleep continuity. J Affect Dis 28:1-6
46. Uhde TW, Roy-Byrne P, Gilling JC, Mendelson WB, Boulenger JP, Vittone BJ, Post RM (1984) The sleep of patients with panic disorder: a preliminary report. Psychiatry Res 12:251-259
47. Brown TM, Black B, Uhde TW (1994) The sleep architecture of social phobia. Biol Psychiatry 35:420-421
48. Grabe HJ, Meyer C, Hapke U, Rumpf HJ, Freyberger HJ, Dilling H, John U (2001) Lifetime-comorbidity of obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in Northern Germany. Eur Arch Psychiatry Clin Neurosci 251: 130-135
49. Keshavan MS, Tandon R (1993) Sleep abnormalities in schizophrenia: Pathophysiological significance. Psychol Med 23:831-835
50. Gillin JC, Smith TL, Irwin M, Kripke DF, Brown S, Schuckit M (1990) Short REM latency in primary alcoholic patients with secondary depression. Am J Psychiatry 147:106-109
51. Moore P, Seifritz E, Schlosser A, Greenfield D, Stahl S, Rapaport M, Kelsoe J (2001) Rapid tryptophan depletion plus a serotonin 1A agonist: competing effects on sleep in healthy men. Neuropsychopharmacol 25:S40-S44
52. Jouvet M (1969) Biogenic amines and the states of sleep. Science 163:32-41
53. Siegel JM (2000) Brainstem mechanisms generating REM sleep. In: Kryger MH, Roth T, Dement WC (eds) Priciples and Practice of Sleep Medicine, 3rd edn. W.B. Saunders Company, Philadelphia, London, Toronto, pp 112-133
54. Koella WP, Feldstein A, Czicman JS (1968) The effect of pchlorophenylalanine on the sleep of cats. Electroencephalogr Clin Neurophysiol 25:481-490
55. Weitzman ED, Rapport MM, McGregor P, Jacoby J (1968) Sleep patterns of the monkey and brain serotonin concentration: effect of p- chlorophenylalanine. Science 160:1361-1363